Proactive Investors - Run By Investors For Investors

Namaste expands patient referral network through new agreement with ARBR

The agreement allows the Namaste MD application to act as a direct-connect platform to enable patients to immediately transition from clinical consultation to connect with a medical professional
medical cannabis
Through an existing agreement, ARBR has an 11,000-strong network of pharmacies across Canada

Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTFF) announced Thursday that it has signed a new agreement to incorporate the company’s integrated telemedicine application into a clinical referral platform.

ARBR (2103486 Alberta Ltd) is a web-based tool to help pharmacists and clinicians facilitate and support patients seeking medical cannabis.

The agreement allows the Namaste MD application to act as a direct-connect platform to enable patients to immediately transition from clinical consultation to connect with a medical professional.

READ: Namaste and True Leaf join forces to sell hemp-based pet products directly to consumers

ARBR has an existing agreement with one of Canada’s largest generic pharmaceutical manufacturers with an 11,000-strong network of pharmacies across the country.

Namaste’s CannMart will be the preferred platform to execute the agreement, the company said in a release, given its large selection of licensed producers, strains and other cannabis products.

"We continue to find innovative ways to expand our network and build the world's most customer focused cannabis marketplace," said Meni Morim, Interim CEO at Namaste.

"We're leveraging in-house developed technology, like NamasteMD, to support tools like ARBR. This relationship opens a new channel to medical cannabis patients and allows the adult-use cannabis consumer to utilize their existing pharmacy relationships."

Morim said the Toronto-based Namaste’s goal is to provide a seamless transition from consulting a pharmacist about personal cannabis needs to being able to get a medical document and order product “near instantaneously.”

"This agreement with a leading technology platform like ARBR continues to demonstrate our unique approach to the cannabis market and will help accelerate our growth." 

"NamasteMD and the CannMart platform are a great way for pharmacists using our ARBR cannabis application to connect their customers with medical professionals and help service their customers' needs," said Kit Poon, CEO of ARBR. "We're excited to work with the team at Namaste to maximize the benefit from this relationship."

Namaste operates numerous e-commerce platforms with multiple websites under various brands.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

View full N profile View Profile

Namaste Technologies Inc Timeline

Related Articles

Surgery
February 20 2019
Earlier this month, Tissue Regenix reported full-year results showing revenues more than doubled last year to £11.6mln, up from £5.2mln a year earlier
antibodies
May 02 2019
Avacta is using Affimers to develop its own cancer therapy, but it also licenses the technology to other companies, including major pharma group ModernaTX and LG Chem Life Sciences
Empty lab
September 19 2018
Management has made some tough decisions, cutting the cost base, since a disappointing first-half performance and expects the benefits to really kick in next year
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use